Clinical Trial Update: Safety and Efficacy of AM712 in Patients with NAMD [Phase 1]

View source ↗

Summary

This update reports Phase 1 safety and preliminary efficacy results for AM712 in patients with Neovascular Age-related Macular Degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• AM712

Snippet

Sponsor: AffaMed Therapeutics Limited | Conditions: Neovascular Age-related Macular Degeneration | Phase 1 | Status: COMPLETED